Cui; Wenge

Patent Applications and Registrations

Patent applications and USPTO patent grants for Cui; Wenge.The latest application filed is for "imidazo(4,5-b) pyridin-2-yl amides as kv7 channel activators".

Company Profile

0.12.14

Cui; Wenge - Schenectady NY
Cui; Wenge - Clifton Park NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Imidazo(4,5-b) Pyridin-2-yl Amides As Kv7 Channel Activators App 20170240547 - Resnick; Lynn ; et al.	2017-08-24
Imidazo(4,5-B) pyridin-2-yl amides as K.sub.V7 channel activators Grant 9,650,376 - Resnick , et al. May 16, 2	2017-05-16
Tricyclic compounds and PBK inhibitors containing the same Grant 9,453,025 - Nakamura , et al. September 27, 2	2016-09-27
Aryl- and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin Grant 9,403,776 - Molino , et al. August 2, 2	2016-08-02
Imidazo(4,5-b) Pyridin-2-yl Amides As Kv7 Channel Activators App 20160031875 - Resnick; Lynn ; et al.	2016-02-04
Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin Grant 9,096,546 - Guzzo , et al. August 4, 2	2015-08-04
Tetrahydroisoquinolines And Intermediates Therefor App 20150191494 - Lobben; Paul ; et al.	2015-07-09
Tricyclic Compounds and PBK Inhibitors Containing the Same App 20150183799 - NAKAMURA; Yusuke ; et al.	2015-07-02
Tricyclic compounds and PBK inhibitors containing the same Grant 8,962,648 - Nakamura , et al. February 24, 2	2015-02-24
Aryl- And Heteroaryl-substituted Tetrahydrobenzazepines And Use Thereof To Block Reuptake Of Norepinephrine, Dopamine, And Serotonin App 20140296514 - Molino; Bruce F. ; et al.	2014-10-02
Aryl- and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin Grant 8,791,101 - Molino , et al. July 29, 2	2014-07-29
Tricyclic Compounds And Pbk Inhibitors Containing The Same App 20130178459 - Nakamura; Yusuke ; et al.	2013-07-11
Tetrahydroisoquinolines and intermediates therefor Grant 8,420,811 - Lobben , et al. April 16, 2	2013-04-16
Tetrahydroisoquinolines And Intermediates Therefor App 20130060027 - Lobben; Paul ; et al.	2013-03-07
Aryl- and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin Grant 7,956,050 - Molino , et al. June 7, 2	2011-06-07
Processes For Preparing Tetrahydroisoquinolines App 20110077400 - Lobben; Paul ; et al.	2011-03-31
Aryl- And Heteroaryl-substituted Tetrahydrobenzazepines And Use Thereof To Block Reuptake Of Norepinephrine, Dopamine, And Serotonin App 20110046114 - Molino; Bruce F. ; et al.	2011-02-24
Aryl-and Heteroaryl-substituted Tetrahydrobenzo-1,4-diazepines And Use Thereof To Block Reuptake Of Norepinephrine, Dopamine, And Serotonin App 20100137287 - Guzzo; Peter R. ; et al.	2010-06-03
Aryl- And Heteroaryl-substituted Tetrahydrobenzazepines And Use Thereof To Block Reuptake Of Norepinephrine, Dopamine, And Serotonin App 20090118260 - MOLINO; Bruce F. ; et al.	2009-05-07
Aryl-and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin App 20080207595 - Molino; Bruce F. ; et al.	2008-08-28
Aryl-and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin App 20070021408 - Molino; Bruce F. ; et al.	2007-01-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.